Table 3

Adverse events observed in patients during the trial period

EventNumber of patientsNumber of events
Total adverse events1084
Treatment-unrelated adverse events1074
 Serious adverse event22
 Mild to moderate adverse events1072
 Common (occurred more than two patients)
  C-reactive protein elevation22
Treatment-related adverse events610
 Serious adverse event00
 Mild to moderate adverse events610
  Appetite loss11
  Oral aphtha11
  Reflux oesophagitis11
  γ-GTP elevation11
  Hiatal hernia11
  • *CK, creatine kinase.